Enhancing Colorectal Cancer Screening Specificity by Integrating Fecal MicroRNA Signature With Fecal Immunochemical Test and Fecal Occult Blood Test. - Suppr | 超能文献

Enhancing Colorectal Cancer Screening Specificity by Integrating Fecal MicroRNA Signature With Fecal Immunochemical Test and Fecal Occult Blood Test.

作者信息

Noursina Ali, Safari Farzad

机构信息

School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

Gastroenterology. 2024 Feb;166(2):358. doi: 10.1053/j.gastro.2023.06.012. Epub 2023 Jun 17.

DOI:10.1053/j.gastro.2023.06.012

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Enhancing Colorectal Cancer Screening Specificity by Integrating Fecal MicroRNA Signature With Fecal Immunochemical Test and Fecal Occult Blood Test.

Gastroenterology. 2024 Feb;166(2):358. doi: 10.1053/j.gastro.2023.06.012. Epub 2023 Jun 17.

2

FECAL OCCULT BLOOD: A COMPARISON OF CHEMICAL AND IMMUNOCHEMICAL TESTS.粪便潜血：化学检测与免疫化学检测的比较

Arq Gastroenterol. 2018 Apr-Jun;55(2):128-132. doi: 10.1590/S0004-2803.201800000-22.

3

Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.基于人群的结直肠癌筛查中结肠镜检查和粪便免疫化学检测的优化使用：一项使用日本数据的成本效益分析

Jpn J Clin Oncol. 2016 Feb;46(2):116-25. doi: 10.1093/jjco/hyv186. Epub 2015 Dec 18.

4

Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test-Based Screening for Colorectal Cancer.粪便 microRNA 算法提高粪便免疫化学试验筛查结直肠癌的效果。

Clin Gastroenterol Hepatol. 2021 Feb;19(2):323-330.e1. doi: 10.1016/j.cgh.2020.02.043. Epub 2020 Feb 28.

5

Application of the fecal microRNA test to the residuum from the fecal occult blood test.粪便微小 RNA 检测在粪便潜血试验残留下的应用。

Jpn J Clin Oncol. 2013 Jul;43(7):726-33. doi: 10.1093/jjco/hyt068. Epub 2013 May 14.

6

Role of double-contrast barium enema in colorectal cancer screening based on fecal occult blood.基于粪便潜血的双重对比钡灌肠在结直肠癌筛查中的作用

Tumori. 2002 Mar-Apr;88(2):95-8. doi: 10.1177/030089160208800203.

7

A quantitative immunochemical fecal occult blood test for colorectal neoplasia.一种用于结直肠肿瘤的定量免疫化学粪便潜血试验。

Ann Intern Med. 2007 Feb 20;146(4):244-55. doi: 10.7326/0003-4819-146-4-200702200-00003.

8

From guaiac to immune fecal occult blood tests: the emergence of technology in colorectal cancer screening.从愈创木脂法到免疫粪便潜血检测：结直肠癌筛查技术的兴起

Gastroenterol Nurs. 2005 Mar-Apr;28(2):90-6. doi: 10.1097/00001610-200503000-00002.

9

Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results.粪便潜血试验结果为阴性的男性比结果阳性的女性更易患有结直肠肿瘤。

Int J Cancer. 2014 Jun 15;134(12):2927-34. doi: 10.1002/ijc.28618. Epub 2013 Dec 11.

10

Cost-effectiveness of colonoscopy in screening for colorectal cancer.结肠镜检查在结直肠癌筛查中的成本效益

Ann Intern Med. 2000 Oct 17;133(8):573-84. doi: 10.7326/0003-4819-133-8-200010170-00007.

引用本文的文献

1

Fecal miRNAs as potential biomarkers for early detection of colorectal cancer: An updated review.粪便微小RNA作为早期检测结直肠癌的潜在生物标志物：最新综述

Biomed J. 2025 Feb;48(1):100769. doi: 10.1016/j.bj.2024.100769. Epub 2024 Jul 17.